Your cornea (the clear “window” at the front of the eye) is covered by a very thin skin called the corneal epithelium. That skin constantly wears out and must be replaced. The limbus—a narrow ring where the clear cornea meets the white part of the eye—houses limbal stem cells. These special cells act like a repair team and a barrier. They make fresh corneal cells and keep the pink conjunctival tissue from crawling onto the cornea.

Limbal Stem Cell Deficiency (LSCD) happens when those limbal stem cells are lost, damaged, or cannot work well. When that repair team fails, the corneal surface breaks down, heals poorly, gets blood vessels, and may get covered by conjunctival tissue (“conjunctivalization”). Vision then becomes blurry, light hurts, and the eye can feel constantly irritated. In short: LSCD is a surface failure of the cornea because its stem-cell supply is missing or sick. EyeWikiFrontiers

Your cornea—the clear “windshield” in front of the eye—needs a steady supply of fresh surface cells to stay smooth and transparent. Those replacement cells are made by special stem cells that live in a narrow ring at the edge of the cornea called the limbus. In limbal stem cell deficiency (LSCD), these stem cells are damaged, used up, or blocked from working. When that happens, the cornea can’t heal properly. The surface breaks down, blood vessels can grow onto the cornea, the clear cornea turns hazy or scarred, and vision drops. People often feel pain, burning, light sensitivity, and constant tearing because the exposed nerves on the cornea get irritated. EyeWikiAmerican Academy of Ophthalmology


Types of LSCD

Doctors group LSCD in a few practical ways. These labels help describe how much, where, and why the problem exists.

1) By cause

  • Primary (inborn or internal reasons): The person is born with or develops a body-wide condition that harms limbal stem cells. Examples include aniridia (a genetic eye disorder) or certain rare syndromes. The limbal niche is weak from the start. AAO Journal

  • Secondary (outside damage): Something from outside injures the limbus—like chemical burns, contact lens overuse, severe inflammatory disease, or multiple eye surgeries—and the stem cells are lost over time. PMCAnnals of Eye Science

2) By extent

  • Focal or sectoral: Only a slice of the limbus is affected. Symptoms can be milder and patchy.

  • Partial: A large part of the limbus is unhealthy but some stem cells survive.

  • Total: Almost all limbal stem cells are gone. The cornea is widely covered by vessels and conjunctival tissue, and vision is often very poor. EyeWiki

3) By laterality

  • Unilateral: One eye is affected.

  • Bilateral: Both eyes are affected (common in severe chemical injuries, autoimmune diseases, or genetic causes).

4) By clinical stage (simple idea)

Modern staging systems look at two easy-to-see things

  • (1) How much of the central 5 mm of the cornea is involved (this is the “visual center”), and
  • How much of the limbus is damaged around the corneal ring.
    The more the central zone and more clock-hours of limbus are involved, the higher the stage. Staging helps plan treatment and follow progress. PMC

Common causes of LSCD

  1. Alkali chemical burns (for example, lime or lye): Strong alkalis soak into tissues fast, destroy limbal structures, and wipe out the stem cells. Even after first-aid, progressive damage can continue. PMC

  2. Acid chemical burns: Acids usually coagulate the surface and may be a bit less penetrating than alkalis, but severe burns still kill limbal cells and scar the surface. PMC

  3. Thermal burns (heat injuries): Fire, steam, hot oil, or fireworks can burn the limbus and cause stem-cell loss with long-term surface instability. PMC

  4. Contact lens overuse or abuse: Tight lenses, poor oxygen transmission, overwear, and rubbing during removal can chronically stress the limbus. Over years, this can lead to “contact lens–induced LSCD.” Early signs can be subtle and patchy. PMCEyeWiki

  5. Stevens–Johnson syndrome / toxic epidermal necrolysis: A severe immune reaction—often to medicines or infection—can blister the eyelids and ocular surface, damaging the limbus in a lasting way. Annals of Eye Science

  6. Ocular cicatricial pemphigoid (OCP): This autoimmune disease scars the conjunctiva and eyelids. Scarring drags on the limbus and destroys the stem-cell niche over time. A conjunctival biopsy confirms the diagnosis. PMC

  7. Aniridia (genetic): A mutation (often PAX6) leads to poor limbal niche development—“aniridia-related keratopathy.” LSCD slowly appears as the person ages. IOVS

  8. Graft-versus-host disease (after bone-marrow transplant): The immune attack dries and inflames the ocular surface; chronic damage can involve the limbus. PMC

  9. Severe chronic allergic eye disease (like vernal or atopic keratoconjunctivitis): Constant inflammation, rubbing, and toxic tears damage limbal cells. PMC

  10. Severe dry eye / autoimmune surface disease (e.g., Sjögren): A very dry, inflamed surface cannot feed the limbal niche properly, causing stem-cell failure over time. PMC

  11. Multiple or aggressive ocular surface surgeries: Repeated pterygium removals, conjunctival autografts, or limbal incisions may partially remove or scar the limbus. PMC

  12. Radiation (therapeutic or accidental): Radiation injures dividing cells and limbal vessels; delayed LSCD can appear months to years later. PMC

  13. Severe infectious keratitis extending to the limbus: Bad infections and their treatments can destroy limbal tissue; later the cornea cannot maintain a healthy skin. EyeWiki

  14. Topical medication toxicity (for example, long-term preservatives like benzalkonium chloride): Chronic exposure irritates and inflames the limbus, slowly depleting stem-cell health. PMC

  15. Mechanical trauma (fingernails, paper cuts, vegetative injuries): Repeated or deep limbal scrapes may set off localized LSCD. PMC

  16. Epidermal or ectodermal genetic syndromes (e.g., EEC syndrome): These can affect skin and ocular surface development, including the limbus. PMC

  17. Limbal ischemia after severe inflammation or autoimmune corneal melt: When blood supply around the limbus is lost, the stem-cell “home” collapses. PMC

  18. Sulfur mustard exposure (chemical weapon): This specific toxin can cause delayed LSCD with scarring and chronic defects. PMC

  19. Severe trachoma and chronic scarring conjunctivitis: Long-standing scarring disorders contract the conjunctiva and damage the limbus. PMC

  20. Limbal tumors or tumor excisions: Either the disease itself or its removal can wipe out local stem cells, leading to sectoral LSCD. PMC


Symptoms

  1. Blurry vision that does not clear with blinking.

  2. Light sensitivity (photophobia)—bright rooms or sunlight hurt.

  3. Eye redness that seems constant or keeps coming back.

  4. Sandy, gritty, or foreign-body feeling all day.

  5. Burning and stinging of the eyes.

  6. Tearing or watery eyes (the surface is unstable, so tears spill).

  7. Dryness feeling even if the eye looks wet (tear quality is poor).

  8. Pain or ache, especially with wind, smoke, or air-conditioning.

  9. Fluctuating vision—better in the morning, worse by evening.

  10. Glare, halos, and starbursts around lights at night.

  11. Mucus strings or filaments on the surface or in the corner.

  12. Poor contact-lens tolerance—lenses feel rough or impossible to wear.

  13. Recurrent surface erosions—sudden sharp pain on waking, like a scratch.

  14. Slow-healing surface wounds—a scratch stays open for days.

  15. Frequent infections or ulcer-like spots when the surface breaks down. American Academy of Ophthalmology


Diagnostic tests

Key idea: Doctors first examine the eye carefully, then confirm the diagnosis with special surface sampling and non-invasive imaging. A few tests check tears and eyelids. Sometimes electrodiagnostic tests help rule out problems deeper in the eye.

A) Physical exam at the slit lamp

1) Visual acuity (VA) chart test
What it is: Reading letters to measure sharpness.
Why it matters: VA shows how much the surface irregularity is harming vision. Worsening VA despite clean media often hints at severe surface disease.

2) External inspection and eyelid exam
What it is: Looking for lid margin disease, scarring, inward/outward turning lids, and short or scarred conjunctiva (symblepharon).
Why it matters: Eyelid and conjunctival scarring diseases (like OCP or SJS) commonly drive LSCD.

3) Slit-lamp biomicroscopy
What it is: A microscope exam of the cornea and limbus.
What doctors see in LSCD: Loss of the normal limbal landmarks (palisades of Vogt), whorl-like cloudy epithelium, superficial blood vessels growing onto the cornea, and a hazy, fragile surface. American Academy of Ophthalmology

4) Fluorescein staining pattern
What it is: A safe yellow dye shows defects and rough spots under blue light.
Why it matters: In LSCD the dye often highlights late-staining, whorl-shaped defects and non-healing edges that point to poor epithelial renewal. EyeWiki

5) Vital stains (rose bengal or lissamine green)
What it is: Dyes that label sick or unprotected cells.
Why it matters: They map areas of surface damage and mucin loss typical of ocular surface failure.

6) Neovascularization grading
What it is: Noting how far blood vessels have crept onto the cornea.
Why it matters: The healthy cornea should have no vessels; new vessels are a red flag for stem-cell failure and chronic inflammation. American Academy of Ophthalmology

B) Manual and bedside tear-film / surface tests

7) Schirmer test (tear quantity)
How it works: A tiny paper strip in the lower lid measures tear production over 5 minutes.
Why it matters: Severe dryness worsens LSCD and slows healing.

8) Tear film break-up time (TBUT)
How it works: After fluorescein, the doctor times when the tear film first breaks.
Why it matters: An unstable tear film means the surface is not protected, aggravating epithelial stress.

9) Corneal esthesiometry (Cochet-Bonnet)
How it works: A thin nylon filament gently touches the cornea to test sensitivity.
Why it matters: Nerve loss (low sensitivity) signals a compromised surface and poorer healing.

10) Eyelid eversion and fornix depth check
How it works: The lids are flipped to look for scarring bands (symblepharon) and shrinkage.
Why it matters: Scarring diseases shorten the fornix and pull on the limbus—classic drivers of LSCD.

C) Laboratory / pathological confirmation

11) Impression cytology with cytokeratin markers
How it works: A soft filter paper gently lifts surface cells. In the lab, antibodies stain special proteins: CK12 marks true corneal epithelium, while CK7/CK13/CK19 mark conjunctival cells.
What it shows in LSCD: Loss of CK12 and gain of CK7/13/19 on the cornea confirm that conjunctival-type cells have replaced corneal cells—proof of LSCD. PMCIOVS

12) Goblet cell detection (PAS stain or MUC5AC)
How it works: The same impression sample is stained to find goblet cells (normal in conjunctiva, abnormal on cornea).
Why it matters: Goblet cells on the cornea are a hallmark of conjunctivalization in LSCD. ScienceDirect

13) OCP work-up: conjunctival biopsy with direct immunofluorescence
Why: If scarring pemphigoid is suspected, a biopsy can show immune deposits along the basement membrane—key to diagnosing and treating the root cause. PMC

14) Inflammation markers on surface cells (e.g., HLA-DR)
What it adds: Helps document immune activation on the ocular surface and monitor response in research or specialized clinics.

15) Microbiology when ulcers or infections are present
When used: If the fragile surface breaks down and gets infected, corneal scrapings or cultures guide immediate treatment.

D) Electrodiagnostic tests

These tests do not diagnose LSCD directly; they help exclude deeper eye problems when vision is worse than the surface looks.

16) Visual evoked potential (VEP)
What it is: Measures the brain’s response to visual signals.
Why: If VEP is normal but vision is poor, the problem is likely at the surface (such as LSCD), not the optic nerve or brain.

17) Full-field or multifocal electroretinography (ERG)
What it is: Tests retinal function.
Why: A normal ERG supports a surface-driven vision loss, focusing attention back on the cornea.

E) Imaging

18) In vivo confocal microscopy (IVCM)
What it shows: Cell-level “microscope” images of the limbus and cornea without touching the tissue.
In LSCD: It often shows loss of the palisades of Vogt, abnormal epithelial cell size/shape, and subepithelial vessel changes. IVCM findings agree well with impression cytology. AjoPubMed

19) Anterior segment OCT (AS-OCT) with epithelial mapping
What it shows: Cross-sections of the cornea and limbus; thickness maps of the epithelium.
In LSCD: Irregular or thinned epithelium and interface changes help map the disease and guide surgery planning. Annals of Eye Science

20) Corneal topography / tomography
What it shows: Curvature and 3-D shape of the cornea.
In LSCD: Surface irregular astigmatism and poor optics correspond to the areas of unhealthy epithelium and vessels, explaining glare and fluctuating vision.

Non-pharmacological treatments

These are “no-drug” or procedure-light strategies that protect the surface, reduce triggers, and prepare the eye for any future surgery.

  1. Stop contact lens wear (at least temporarily)
    If contact lenses caused or worsened the problem, pausing lens use gives the limbus a chance to recover and prevents further micro-trauma. Later, some patients can return to scleral or PROSE lenses under medical supervision. EyeWiki

  2. Scleral / PROSE lenses
    These large “vaulting” lenses don’t touch the cornea. They hold a pool of sterile saline against the eye, acting like a liquid bandage that shields the surface and can sharpen vision in LSCD. They’re custom-fit by specialists. EyeWiki

  3. Preservative-free lubrication (as a habit)
    Frequent, preservative-free artificial tears and nighttime ointments help the cornea glide with each blink and reduce micro-abrasions that trigger erosions.

  4. Moisture chamber glasses & humidification
    “Goggle-style” glasses and room humidifiers slow down tear evaporation, keeping the surface stable.

  5. Punctal occlusion (temporary plugs or cautery)
    Closing the tear drain helps you keep your own tears longer. This supports healing in dry, unstable surfaces—common in LSCD. EyeWiki

  6. Eyelid hygiene and warm compresses
    If oil glands in the lids are clogged, the tear film becomes unstable. Daily lid hygiene restores the oil layer and calms inflammation that irritates the limbus.

  7. Treat blepharitis and meibomian gland dysfunction (MGD)
    Office-based gland clearing (e.g., thermal pulsation) and home care reduce toxins and enzymes that can damage the corneal surface.

  8. UV and wind protection
    Wraparound sunglasses limit UV damage and reduce airborne irritants that trigger reflex rubbing and inflammation.

  9. Smoking cessation
    Smoke worsens surface inflammation and delays healing; quitting helps the cornea recover.

  10. Avoid toxic drops and preservatives
    Long-term benzalkonium chloride (BAK) and frequent vasoconstrictor “get-the-red-out” drops can hurt the ocular surface; preservative-free choices are safer for LSCD.

  11. Protective eye shields at night
    For exposure or lagophthalmos (incomplete eyelid closure), shields and taping reduce overnight drying and morning erosions.

  12. Bandage soft contact lens (short-term only, under supervision)
    A temporary bandage lens can protect raw epithelium and relieve pain while the surface heals, especially after procedures. (This is different from routine contact lens wear that caused disease.) EyeWiki

  13. Debridement of loose epithelium (in clinic)
    Gently removing non-adherent cells helps a healthier sheet of cells re-grow and stick.

  14. Control ocular allergy
    Cold compresses and allergen avoidance stop the itch–rub cycle that fuels limbal micro-trauma.

  15. Manage systemic triggers
    Control autoimmune disease, vitamin A deficiency, or severe eczema/atopy that destabilize the ocular surface. WHO IRIS+1

  16. Nutritional optimization (see supplements section)
    Correcting deficiencies (A, D) supports epithelial health and healing. WHO IRISPubMed

  17. Education on safe chemical handling
    If LSCD followed a burn, reinforce splash protection and first-aid rinsing to prevent re-injury.

  18. Frequent blinking & screen ergonomics
    Structured blink breaks and proper monitor height reduce evaporation and friction.

  19. Treat coexisting neurotrophic issues
    If corneal nerves are impaired, targeted therapy and surface protection help epithelial recovery.

  20. Amniotic membrane as a biologic “bandage”
    This is technically a procedure but not a drug: a thin, natural membrane placed on the eye calms inflammation, releases growth factors, and promotes epithelial healing; it’s often used as an adjunct in LSCD care. PubMedJAMA Network


Drug treatments

  1. Preservative-free artificial tears / gels / ointments
    Purpose: Constant lubrication and friction control.
    How used: Tears hourly to q2–3h; gels daytime; ointment at bedtime.
    Mechanism: Replaces tear volume, stabilizes tear film, reduces micro-trauma.
    Side effects: Temporary blur from gels/ointment; very safe.

  2. Topical corticosteroids (e.g., prednisolone acetate 1% or loteprednol 0.5%)
    Purpose: Calm surface inflammation and help quiet corneal neovascularization early.
    Dose/time: QID, then taper over weeks per response.
    Mechanism: Suppress inflammatory cytokines and MMP-9 that degrade epithelial adhesion.
    Key cautions: Can raise eye pressure, promote infection or cataract with long use; taper with doctor guidance. American Academy of OphthalmologyScienceDirect

  3. Topical cyclosporine A (0.05–0.1%)
    Purpose: Steroid-sparing control of chronic surface inflammation.
    Dose/time: BID; benefits build over 1–3 months.
    Mechanism: Calcineurin inhibition; reduces T-cell–driven inflammation.
    Side effects: Temporary burning, redness.

  4. Topical tacrolimus (0.02–0.03% ointment or drops)
    Purpose: Alternative to cyclosporine for stubborn inflammation or allergy-driven disease.
    Dose/time: HS to BID; titrate to effect.
    Mechanism: Calcineurin inhibition.
    Side effects: Stinging, rare local irritation.

  5. Oral doxycycline (50 mg twice daily or 100 mg daily for weeks)
    Purpose: Stabilize the epithelium in erosions and MGD-related inflammation.
    Mechanism: Inhibits matrix metalloproteinases (especially MMP-9); anti-inflammatory.
    Side effects: Stomach upset, sun sensitivity; avoid in pregnancy/children. PubMedScienceDirectAmerican Academy of Ophthalmology

  6. Topical N-acetylcysteine (NAC) 5–10% drops
    Purpose: Dissolve sticky mucus/filaments and improve comfort when filaments form on a compromised surface.
    Dose/time: QID (typical) under prescription compounding.
    Mechanism: Mucolytic; also reduces MMP-9 expression in vitro.
    Side effects: Transient burn/irritation; has a sulfur smell. ScienceDirectPMC

  7. Autologous serum tears (AST) 20–50%
    Purpose: Biological “super-tears” that contain growth factors, vitamins, and proteins similar to natural tears. Helpful in persistent epithelial defects and early/partial LSCD.
    Dose/time: QID–8×/day; kept refrigerated/frozen per protocol.
    Mechanism: Supports limbal niche health and epithelial healing.
    Side effects: Rare contamination risk; requires clean preparation. PMCPubMed

  8. Platelet-rich plasma (PRP) eye drops
    Purpose: Higher concentration of growth factors to stimulate epithelial repair when AST alone is insufficient.
    Dose/time: Similar to AST; varies by protocol.
    Mechanism: Platelet-derived growth factors support cell migration and adhesion.
    Side effects: Similar to AST; must be prepared safely. Annals of Eye Science

  9. Anti-VEGF therapy (e.g., bevacizumab topical or subconjunctival)
    Purpose: Regress abnormal corneal blood vessels that invade the cornea in LSCD.
    Dose/time: Specialist-directed; often series of injections/drops.
    Mechanism: Blocks VEGF to reduce neovascularization.
    Key cautions: Over-aggressive dosing or timing may delay epithelial healing or thin the cornea; must be used judiciously. PMCMDPIScienceDirect

  10. Topical antibiotic ointment (e.g., erythromycin) when the surface is open
    Purpose: Infection prophylaxis while the epithelium heals.
    Dose/time: HS to QID short-term.
    Mechanism: Reduces bacterial load.
    Side effects: Mild blur, rare allergy.

(Emerging/adjunct) ROCK inhibitors (e.g., ripasudil, netarsudil) are being explored for corneal wound healing. Evidence is stronger in endothelial disease; role in LSCD is still investigational and must be individualized. PMC+1ScienceDirect


Dietary, molecular, and other supportive supplements

(Use in addition to medical care; discuss with your clinician—some evidence is mixed.)

  1. Vitamin A (diet and, if deficient, medical supplementation)
    Supports healthy corneal and conjunctival epithelium; deficiency leads to xerophthalmia and serious corneal disease. WHO IRIS+1

  2. Vitamin D (if low)
    Low vitamin D is linked with tear film instability; supplementation in deficient people can improve tear quality and surface markers. PubMedScienceDirect

  3. Omega-3 fatty acids (EPA/DHA)
    May help in some dry eye subtypes, but high-quality trials show mixed results (the large NEJM DREAM study found no overall benefit vs placebo). Consider a food-first approach (fatty fish) and decide case-by-case. New England Journal of MedicinePMC

  4. Vitamin C (ascorbic acid)
    Supports collagen and epithelial repair; helps reduce scarring and neovascularization in laboratory and clinical contexts. ScienceDirect

  5. Vitamin E
    Antioxidant partner with vitamin C in corneal wound healing in some studies; may support tear stability in select groups. Lippincott Journals

  6. Zinc (if deficient)
    Essential for vitamin A metabolism and epithelial repair; deficiency impairs healing. Avoid excess. Optometry Times

  7. Adequate protein
    Provides amino acids (building blocks) for tissue repair and enzymes that remodel the surface.

  8. Hydration (water intake)
    Maintains tear volume and mucin function; dehydration worsens symptoms.

  9. Antioxidant-rich foods (berries, leafy greens, colorful vegetables)
    Help neutralize oxidative stress on the ocular surface.

  10. Flaxseed / plant omega-3 (ALA)
    A plant-based alternative that some patients tolerate better; conversion to EPA/DHA is limited but may still help certain dry eye patterns.

  11. Curcumin (turmeric extract)
    Anti-inflammatory activity systemically; limited direct ocular data—use as general support if tolerated.

  12. L-carnitine
    Investigated for tear film and inflammatory markers in some studies; consider as adjunct only with clinician guidance. Frontiers

  13. Vitamin B12 (if deficient)
    Supports nerve health and epithelial maintenance; deficiency can worsen surface sensitivity.

  14. Avoid excess alcohol
    Alcohol dehydrates and may worsen inflammation.

  15. Limit ultra-processed, very salty foods
    High salt can dehydrate; processed foods may increase systemic inflammation that reflects on the ocular surface.


Regenerative, and stem-cell–related medicines

These are mostly systemic immunosuppressants used to protect allograft limbal transplants (when donor stem cells come from another person) and one approved cell therapy:

  1. Oral cyclosporine A
    Typical starting 3–4 mg/kg/day, then taper; reduces rejection of limbal allografts (e.g., KLAL). Monitor blood pressure, kidneys. PMC

  2. Oral tacrolimus
    Alternative/adjunct calcineurin inhibitor; monitor kidneys, blood pressure, and drug levels. PMC

  3. Mycophenolate mofetil
    Antimetabolite that suppresses lymphocyte proliferation; often part of “triple therapy.” Watch for GI upset, low blood counts. PubMed

  4. Azathioprine
    Another antimetabolite option; requires blood count and liver monitoring; check TPMT activity if available. PubMed

  5. Oral corticosteroids (prednisone)
    Short courses around surgery to calm inflammation; long-term use carries significant systemic risks; taper carefully. PubMed

  6. Holoclar® (ex vivo expanded autologous limbal epithelial cells)
    An EMA-approved cell therapy for adult LSCD from ocular burns. Patient’s own tiny limbal biopsy is expanded in a lab and transplanted to rebuild the corneal surface. Initially conditionally authorized in 2015 and converted to full marketing authorisation in 2024. European Medicines Agency (EMA)PMCholostem.com


Surgeries

  1. SLET — Simple Limbal Epithelial Transplantation
    A small limbal biopsy from the healthy eye is cut into tiny pieces and placed on an amniotic membrane over the damaged cornea. The pieces grow and repopulate the surface. It avoids taking large donor tissue and has good success and vision gains in many series, including long-term data. Why: Rebuilds the patient’s own limbal stem cell pool in unilateral LSCD. PubMedLippincott JournalsAjo

  2. CLAU / lr-CLAL — Conjunctival-Limbal Autograft (from your other eye) or Living-Related Allograft
    A strip of limbus (with conjunctiva) is moved from the healthy eye or a living related donor. Why: For unilateral disease or when a related donor is available; studies suggest lower rejection and better survival than cadaveric KLAL when managed with appropriate immunosuppression. PubMed

  3. KLAL — Keratolimbal Allograft (cadaver donor)
    Cadaver donor tissue carrying limbal stem cells is transplanted to the recipient limbus. Why: For bilateral or severe LSCD where no safe autograft is possible; requires systemic immunosuppression to prevent rejection. EyeWiki

  4. CLET / Holoclar (cultivated limbal epithelial transplantation)
    Stem cells harvested from a tiny biopsy are grown in the lab and then transplanted as a sheet. Why: Minimizes donor-eye risk and provides a standardized cell product; Holoclar is approved in the EU for LSCD from burns. European Medicines Agency (EMA)PMC

  5. Amniotic Membrane Transplantation (AMT)
    A biologic “scaffold” placed on the cornea that reduces inflammation, supports healing, and improves the limbal environment—often combined with stem cell grafts or used to treat persistent epithelial defects. Why: Speeds healing and stabilizes the surface before/after stem-cell procedures. PubMedJAMA Network

(Notes: Other specialized options—including combined procedures and oral mucosal epithelial transplantation)—are considered case-by-case in advanced centers.) PubMed


Prevention tips

  1. Use contact lenses exactly as directed; never sleep in lenses unless prescribed.

  2. Keep perfect contact lens hygiene (case care, solution replacement, no tap water).

  3. Choose preservative-free drops when possible if you use them often.

  4. Wear eye protection at work and when handling chemicals.

  5. Control allergies and avoid eye rubbing.

  6. Treat blepharitis/MGD early to stabilize the tear film.

  7. Protect against UV and wind with wraparound sunglasses.

  8. Don’t “self-medicate” with anesthetic drops or chronic vasoconstrictors.

  9. Eat for eye health (vitamins A, C, D; omega-3 foods) and stay hydrated. WHO IRISPubMed

  10. If you’ve had a chemical burn or severe red eye, rinse first, then seek care immediately.


When to see a doctor urgently

  • Sudden drop in vision, severe pain, or light sensitivity that doesn’t ease.

  • A known chemical splash or thermal burn—after immediate irrigation.

  • A non-healing corneal defect or repeated erosions.

  • New blood vessels creeping onto the cornea or a white spot (possible infection).

  • Worsening redness/tearing despite frequent lubrication.

  • If you wear contact lenses and develop persistent discomfort or blur. American Academy of Ophthalmology


Simple diet “do’s and don’ts” for the ocular surface

Eat more:

  1. Colorful vegetables (carrots, spinach, kale) for vitamin A precursors. WHO IRIS

  2. Citrus, berries, peppers for vitamin C. ScienceDirect

  3. Fatty fish (salmon, sardine, mackerel) 1–2×/week for EPA/DHA. (Supplements are optional; evidence is mixed—food first is sensible.) New England Journal of Medicine

  4. Lean proteins (pulses, eggs, yogurt, fish, poultry) to support tissue repair.

  5. Nuts, seeds, legumes, seafood for zinc (within recommended limits). Optometry Times

Limit/avoid:
6) Excess alcohol (dehydrating).
7) Ultra-processed and very salty foods (worsen dryness).
8) Smoking/tobacco (delays healing).
9) Sugary beverages (spikes inflammation).
10) “Red-out” eye drops used daily—choose preservative-free tears instead.


Frequently asked questions

1) Is LSCD reversible?
Early or partial LSCD can sometimes improve with aggressive surface care, biologic drops (e.g., autologous serum), and protection. Advanced or total LSCD usually needs stem-cell–based surgery to restore a stable surface. Annals of Eye Science

2) Can glasses fix LSCD?
Glasses don’t treat the surface. Scleral/PROSE lenses can improve comfort and vision by covering the cornea with a fluid reservoir. EyeWiki

3) Is LSCD contagious?
No. It’s a tissue-failure problem, not an infection (though infections can complicate it). EyeWiki

4) I only have it in one eye—can you use the other eye to fix it?
Often yes. SLET or CLAU use a small biopsy from the healthy eye to repopulate the damaged one. Surgeons minimize donor-eye risk by keeping the biopsy small. PubMed

5) What if both eyes are affected?
Options include KLAL (cadaver donor) or living-related allograft, sometimes followed later by a corneal transplant for clarity. These require systemic immunosuppression. EyeWikiPubMed

6) What is Holoclar?
A European-approved autologous cultivated limbal epithelial cell therapy for adult LSCD caused by burns. It was first authorized Feb 17, 2015, and transitioned to full authorisation in Feb 2024. European Medicines Agency (EMA)holostem.com

7) How successful are these surgeries?
Success varies by cause and severity. Many SLET and autograft series show high rates of surface stability and meaningful vision gain; long-term data show roughly two-thirds maintain a stable epithelial phenotype. Allografts work but need careful immunosuppression. PubMedAjo

8) Will I need a regular corneal transplant too?
Sometimes. Stem-cell surgery first stabilizes the surface. If scarring remains, a later penetrating or lamellar keratoplasty can improve clarity. The sequence and timing are individualized. AAO Journal

9) Can anti-VEGF drops or injections help the red blood vessels?
Yes—bevacizumab can regress abnormal vessels. Your doctor will time it to avoid slowing epithelial healing and will watch for rare thinning. PMCMDPI

10) Do omega-3 pills help?
Food sources are great; supplements show mixed evidence. The large NEJM DREAM trial found no overall benefit versus placebo. Ask your doctor what fits your case. New England Journal of Medicine

11) What’s the role of amniotic membrane?
It’s a biologic “bandage” that calms inflammation and supports limbal and epithelial healing, often used with stem-cell procedures. PubMed

12) Will I need medicines by mouth after donor stem-cell surgery?
If you receive allogeneic tissue (from someone else), yes—usually a combination of systemic immunosuppressants to prevent rejection. PubMed

13) How long before I see improvement?
With surface optimization, some comfort gains are quick; biologic drops can take weeks; stem-cell surgeries need months for full stabilization. Your team will set expectations based on your case. PubMed

14) Can I wear contact lenses again?
Possibly scleral/PROSE lenses under close supervision. Traditional soft lenses may be unsafe if they originally contributed to LSCD. EyeWiki

15) Is LSCD treatment safe in pregnancy?
Lubricants and many non-drug measures are fine. Some medicines (e.g., doxycycline, systemic immunosuppressants) are not. Always coordinate with your obstetric and eye teams.

Disclaimer: Each person’s journey is unique, treatment planlife stylefood habithormonal conditionimmune systemchronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: August 11, 2025.

 

      To Get Daily Health Newsletter

      We don’t spam! Read our privacy policy for more info.

      Download Mobile Apps
      Follow us on Social Media
      © 2012 - 2025; All rights reserved by authors. Powered by Mediarx International LTD, a subsidiary company of Rx Foundation.
      RxHarun
      Logo
      Register New Account